Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Payables (2023 - 2026)

Updated

Translational Development Acquisition's Payables came in at $1.58 million for Q2 2026, up 872.7% from $162,920 a year earlier and up 118.8% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) Payables (2023 - 2026) Analysis & Trends

At the end of FY2025, Translational Development Acquisition's Payables was $362,311.

  • Going back by year, Payables was $16,189 in FY2024 (-95.4%) and $348,752 in FY2023.
  • The Q2 2026 figure represents the highest quarterly Payables in data going back to Q4 2023.
  • Business Quant data shows TDACU's Payables at $724,323 (Q1 2026), $362,311 (Q4 2025) and $271,083 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.58 Mn
Mar 31, 2026 724,323.00
Dec 31, 2025 362,311.00
Sep 30, 2025 271,083.00
Jun 30, 2025 162,920.00
Mar 31, 2025 225,477.00
Dec 31, 2024 16,189.00
Dec 31, 2023 348,752.00
API Access

Translational Development Acquisition Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=TDACU&period=max&api_key=YOUR_API_KEY